Effect of α-receptor blockers on lower urinary tract symptoms, sexual function and quality of life in young and middle-aged men with benign prostatic hyperplasia.

about

Effect of α-receptor blockers on lower urinary tract symptoms, sexual function and quality of life in young and middle-aged men with benign prostatic hyperplasia.

Item

http://www.wikidata.org/entity/Q41018045

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of α-receptor blockers ...... benign prostatic hyperplasia.

@en

type

Item

label

Effect of α-receptor blockers ...... benign prostatic hyperplasia.

@en

prefLabel

Effect of α-receptor blockers ...... benign prostatic hyperplasia.

@en

P1476

Effect of α-receptor blockers ...... benign prostatic hyperplasia.

@en

P2093

Hongtao Zhen

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Jiechang Ju

http://www.w3.org/2001/XMLSchema#string

Jizheng Wang

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Tongqing Wang

http://www.w3.org/2001/XMLSchema#string

Xiaolong Tang

http://www.w3.org/2001/XMLSchema#string

Yalin Liang

http://www.w3.org/2001/XMLSchema#string

Yaolei Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia

Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model.

Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.

α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.

Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.

Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.

Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead.

Effect of tamsulosin on the pharmacokinetics of dutasteride in Chinese male healthy volunteers.

Transitional Zone Index as a Predictor of the Efficacy of α-Blocker and 5α-Reductase Inhibitor Combination Therapy in Korean Patients with Benign Prostatic Hyperplasia.

P304

587-592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4518

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28672971

http://www.w3.org/2001/XMLSchema#string

P932

5488476

http://www.w3.org/2001/XMLSchema#string